UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
decitabine (1253) 1253
science & technology (1009) 1009
life sciences & biomedicine (978) 978
humans (902) 902
azacitidine - analogs & derivatives (772) 772
oncology (510) 510
azacitidine - pharmacology (469) 469
dna methylation (411) 411
female (367) 367
male (327) 327
hematology (299) 299
animals (266) 266
azacitidine - therapeutic use (251) 251
methylation (243) 243
middle aged (236) 236
cell line, tumor (231) 231
aged (223) 223
dna methylation - drug effects (223) 223
cancer (200) 200
leukemia (172) 172
acute myeloid leukemia (170) 170
azacitidine (165) 165
antimetabolites, antineoplastic - therapeutic use (164) 164
treatment outcome (164) 164
epigenetics (156) 156
mice (154) 154
myelodysplastic syndromes - drug therapy (151) 151
adult (150) 150
gene expression (147) 147
myelodysplastic syndromes (144) 144
azacitidine - administration & dosage (139) 139
myelodysplastic syndrome (138) 138
leukemia, myeloid, acute - drug therapy (136) 136
antimetabolites, antineoplastic - pharmacology (135) 135
dna modification methylases - antagonists & inhibitors (124) 124
5-aza-2'-deoxycytidine (119) 119
enzyme inhibitors - pharmacology (119) 119
chemotherapy (116) 116
biochemistry & molecular biology (115) 115
promoter regions, genetic (115) 115
research (115) 115
pharmacology & pharmacy (109) 109
aged, 80 and over (108) 108
cell biology (108) 108
antineoplastic agents (105) 105
deoxyribonucleic acid--dna (105) 105
antimitotic agents (101) 101
gene expression regulation, neoplastic - drug effects (97) 97
care and treatment (93) 93
apoptosis (92) 92
antineoplastic combined chemotherapy protocols - therapeutic use (90) 90
tumor cells, cultured (89) 89
prognosis (87) 87
antineoplastic agents - therapeutic use (84) 84
mutation (83) 83
analysis (81) 81
antineoplastic agents - pharmacology (80) 80
azacitidine - adverse effects (79) 79
genetic aspects (76) 76
decitabine - pharmacology (74) 74
epigenesis, genetic (73) 73
genetics & heredity (72) 72
hypomethylating agents (71) 71
cpg islands (70) 70
reverse transcriptase polymerase chain reaction (69) 69
dna (68) 68
hematology, oncology and palliative medicine (68) 68
tumors (68) 68
cell line (65) 65
leukemia, myeloid, acute - genetics (64) 64
hemic and lymphatic diseases (63) 63
proteins (63) 63
gene expression regulation, neoplastic (62) 62
cells, cultured (61) 61
medicine & public health (61) 61
cell proliferation - drug effects (60) 60
dose-response relationship, drug (60) 60
medicine, research & experimental (60) 60
patients (60) 60
research & experimental medicine (60) 60
stem cells (60) 60
antimetabolites, antineoplastic - administration & dosage (59) 59
abridged index medicus (58) 58
health aspects (58) 58
rna, messenger - metabolism (57) 57
epigenesis, genetic - drug effects (56) 56
genes (56) 56
hydroxamic acids - pharmacology (56) 56
remission induction (56) 56
drug therapy (55) 55
apoptosis - drug effects (54) 54
myelodysplastic syndromes - genetics (52) 52
retrospective studies (51) 51
5-aza-2′-deoxycytidine (50) 50
clinical trials as topic (50) 50
aml (49) 49
antimetabolites, antineoplastic - adverse effects (48) 48
gene silencing (48) 48
myelodysplastic syndromes - mortality (48) 48
promoter regions, genetic - genetics (48) 48
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1361) 1361
Chinese (36) 36
Japanese (10) 10
French (7) 7
Russian (3) 3
Polish (2) 2
Spanish (2) 2
Turkish (2) 2
Dutch (1) 1
German (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 1528-0020, 09/2018, Volume 132, Issue 11, pp. 1125 - 1133
Journal Article
Current pharmaceutical design, ISSN 1381-6128, 05/2016, Volume 22, Issue 16, pp. 2349 - 2357
Journal Article
Frontiers in immunology, ISSN 1664-3224, 06/2018, Volume 9, pp. 1239 - 1239
γδ T cell-based immunotherapy for osteosarcoma (OS) has shown limited success thus far. DNA-demethylating agents not only induce tumor cell death but also have... 
Decitabine | Osteosarcoma | γδ T cell | UL16-binding protein 1 | MICB | decitabine | osteosarcoma
Journal Article
Drug delivery and translational research, ISSN 2190-393X, 10/2018, Volume 8, Issue 5, pp. 1289 - 1299
Journal Article
Leukemia & lymphoma, ISSN 1042-8194, 04/2018, Volume 59, Issue 4, pp. 821 - 828
We investigated CD25 expression in older (≥60 years) patients with new acute myelogenous leukemia treated with decitabine and plerixafor. Patients resistant to... 
AML | CD25 | decitabine | drug resistance | prognostication | Decitabine | Prognostication | Drug resistance | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Index Medicus
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 2018, Volume 9, Issue 5, pp. 5823 - 5833
To overcome unsatisfactory results of classical low-dose cytarabine (LDAC) of cytarabine ≤20 mg twice daily (BID) subcutaneously for 10 days for patients with... 
Etoposide | Low-intensity chemotherapy | Decitabine | Elderly acute myeloid leukemia | Modified low-dose cytarabine
Journal Article
Journal Article
Journal Article